Post-partum mammalian placenta, its use and placental stem cells therefrom
Patent Number: 7,255,879
Date of First Priority Issue: Wednesday December 6th, 2000
Date Issued: Tuesday August 14th, 2007
Assignee: Anthrogenesis Corporation (Cedar Knolls, NJ)
Inventors: Hariri; Robert J. (Florham Park, NJ)
From Class: Type
Comments: No comments
This patent covers a mesenchymal-like stem cell obtained by first flushing a placenta so that cord blood is substantially cleared, and subsequently perfusing the placenta to collect cells that are CD34 negative and have stem cell properties.
The cell type covered appears to be: positive for one or more of the following markers: SH2, SH3, SH4, CD10, CD29, CD44, CD54, CD90, and OCT-4, AND negative for one or more of the following markers: CD34, CD45, SSEA3 and SSEA4.
One is likely to learn a lot by comparing the prosecution history of this patent with other patents on mesenchymal like stem cells.
View this patent on the USPTO website.
Added to StemCellPatents.com on Sunday August 19th, 2007
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.